Follow up letter to June 5, 2023 meeting with the Minister of Jobs, Economic Development and Innovation during which we discussed the BC Life Sciences Strategy and Novartis' role as a key partner in the province's bioscience ecosystem, including data partnerships, patient access to innovative medicines (including the abscence of a drug named KESIMPTA from public listing) and expanded access to diagnostic equipment.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|